We are live on
!
Find out more
Maravai LifeSciences
MRVI
MRVI
160 hedge funds and large institutions have $375M invested in Maravai LifeSciences in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 46 increasing their positions, 47 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 150 → 160 (+10)
0.28% more ownership
Funds ownership: 90.07% → 90.36% (+0.28%)
2% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 47
Holders
160
Holding in Top 10
4
Calls
$3.19M
Puts
$63K
Top Buyers
| 1 | +$8.97M | |
| 2 | +$7.09M | |
| 3 | +$2.53M | |
| 4 |
TC
Tejara Capital
London,
United Kingdom
|
+$1.31M |
| 5 |
RA
Royce & Associates
New York
|
+$1.24M |
Top Sellers
| 1 | -$5.76M | |
| 2 | -$2.89M | |
| 3 | -$2.39M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.13M |
| 5 |
BlackRock
New York
|
-$1.51M |